Medicare Enrolled

Dr. Jemimah Corpuz, OD

Optometrist · Seattle, WA
Low-engagement
3324 RAINIER AVE S, Seattle, WA 98144
6614286172
In practice since 2016 (9 years)
NPI: 1962947978 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Corpuz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Corpuz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Corpuz

Dr. Jemimah Corpuz is an optometrist in Seattle, WA, with 9 years of NPI registration.

Between the years covered by Open Payments, Dr. Corpuz received a total of $7,345 from 23 pharmaceutical and/or device companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optometrist. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Corpuz is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice $7,345 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$7,345
Total received (2018-2024)
Avg $1,049/year across 7 years
Top 2% in WA for optometrist
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
250
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,345 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$849
2023
$1,223
2022
$1,506
2021
$1,239
2020
$838
2019
$1,009
2018
$682

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb Americas Inc.
$247
ABBVIE INC.
$143
Mallinckrodt Hospital Products Inc.
$137
Tarsus Pharmaceuticals, Inc.
$125
CooperVision Inc.
$120
Oyster Point Pharma, Inc.
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Johnson & Johnson Vision Care, Inc.
$14
Top 3 companies account for 62.2% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$1,537
Johnson & Johnson Vision Care, Inc.
$754
Sun Pharmaceutical Industries Inc.
$660
Mallinckrodt Enterprises LLC
$438
Bausch & Lomb Americas Inc.
$416
Oyster Point Pharma, Inc.
$384
SUN PHARMACEUTICAL INDUSTRIES INC.
$350
Allergan, Inc.
$342
Eyevance Pharmaceuticals LLC
$286
Shire North American Group Inc
$268
Dompe US, Inc.
$265
Bausch & Lomb, a division of Bausch Health US, LLC
$256
Allergan Inc.
$251
Katena Products, Inc.
$194
ABBVIE INC.
$155
Kala Pharmaceuticals, Inc.
$145
CooperVision Inc.
$140
Novartis Pharmaceuticals Corporation
$136
ANI Pharmaceuticals, Inc.
$127
Tarsus Pharmaceuticals, Inc.
$125
AbbVie Inc.
$55
Alcon Vision LLC
$39
Thea Pharma Inc.
$21
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · Acuvue · BTOD · CEQUA · CEQUA (cyclosporine ophthalmic solution) 0.09% · Cequa · DAILIES · EYSUVIS · Flarex · INFUSE · INVELTYS · LOTEMAX SM · LUMIGAN · MIEBO · MiSight Contact Lens · MyDay Contact Lens · OXERVATE · Oxervate · PURIFIED CORTROPHIN GEL · RESTASIS · RESTASIS MULTIDOSE · TYRVAYA · ULTRA · VUITY · XDEMVY · XELPROS · XELPROS (latanoprost ophthalmic emulsion) 0.005% · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for optometrist in WA.

Looking for an optometrist in Seattle?
Compare optometrists in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse optometrists nearby

Geographic Context

Optometrists within 10 mi
702
Per 100K population
31.0
County median income
$122,148
Nearest hospital
SWEDISH MEDICAL CENTER / CHERRY HILL
1.7 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Corpuz is an optometrist, with low-engagement industry engagement in the top 2% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Corpuz receive payments from pharmaceutical companies?
Yes. Dr. Corpuz received a total of $7,345 from 23 companies across 250 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Corpuz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Optometrists in Seattle
Browse optometrists in Seattle ranked by procedure volume and transparency data.
Highest volume
Top Optometrists in WA
Optometrists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Optometrists in WA
Which WA optometrists receive the most from drug and device companies.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
Johnson & Johnson Vision Care, Inc. Payments to Doctors
See all physicians who received payments from Johnson & Johnson Vision Care, Inc.
By company
Sun Pharmaceutical Industries Inc. Payments to Doctors
See all physicians who received payments from Sun Pharmaceutical Industries Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →